Trimetazidine: A new cause for drug-induced parkinsonism? [5]

Movement Disorders

Volumn 20, Issue 8, 2005, Pages 1080-1081

  Sommet, Agnès ^a   Azaïs Vuillemin, Cécile ^b   Bagheri, Haleh ^a,c   Rascol, Olivier ^a,c   Montastruc, Jean Louis ^a,c  

^a Hôpitaux universitaires de Toulouse   (France)

^b Clinique du Parc   (France)

^c Laboratoire de Pharmacologie Médicale et Clinique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NICARDIPINE; TRIMETAZIDINE;

AGED; BRADYKINESIA; CASE REPORT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYNDROME; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LETTER; MALAISE; MUSCLE RIGIDITY; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PRIORITY JOURNAL; RECUMBENCY; SYMPTOM; VERTIGO;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERTENSION; MENTAL STATUS SCHEDULE; PARKINSONIAN DISORDERS; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 26444460350     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20574     Document Type: Letter

References (5)

1. McClellan KJ, Plosker GL. Trimetazidine: a review of its use in stable angina pectoris and other coronary conditions. Drugs 1999; 58:143-157.
2. Marti-Masso JF. Parkinsonismo por trimetazidina. Neurologia 2004;19:392-395.
3. Montastruc JL, Llau ME, Rascol O, Senard JM. Drug-induced parkinsonism: a review. Fundam Clin Pharmacol 1994;8:293-306.
4. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs: actualization of the method used in France. Therapie 1985;40:111-118.
5. Garcia M, Ruiz B, Aguirre C. Parkinsonismo asociado a trimetazidina. Communication to the 5th Congress of the Spanish Society for Pharmacovigilance, Barcelona, Spain 12-13 November 2004.